Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Vallon Pharmaceuticals stock
Learn how to easily invest in Vallon Pharmaceuticals stock.
Vallon Pharmaceuticals completed its $18 million IPO, selling 2.25 million shares at $8 each. Shares of VLON are available for limit orders on Robinhood.
How to buy shares in Vallon Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VLON – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Vallon Pharmaceuticals stock price (NASDAQ: VLON)Use our graph to track the performance of VLON stocks over time.
Vallon Pharmaceuticals shares at a glance
|Latest market close||$0.29|
|52-week range||$0.25 - $8.54|
|50-day moving average||$0.39|
|200-day moving average||$2.50|
|Wall St. target price||$12.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.36|
Buy Vallon Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Vallon Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vallon Pharmaceuticals price performance over time
|1 week (2022-09-27)||-2.52%|
|1 month (2022-09-02)||-25.64%|
|3 months (2022-07-01)||-53.23%|
|6 months (2022-03-31)||-84.57%|
|1 year (2021-10-04)||-95.86%|
|2 years (2020-09-30)||N/A|
|3 years (2019-09-30)||N/A|
|5 years (2017-09-30)||N/A|
Vallon Pharmaceuticals financials
|Gross profit TTM||$100,000|
|Return on assets TTM||-53.98%|
|Return on equity TTM||-129.61%|
|Market capitalisation||$3 million|
TTM: trailing 12 months
Vallon Pharmaceuticals share dividends
We're not expecting Vallon Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- GlaxoSmithKline PLC ADR (GSK.US) (8.46% forward annual dividend yield)
Vallon Pharmaceuticals overview
Vallon Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania. .
Frequently asked questionsWhat percentage of Vallon Pharmaceuticals is owned by insiders or institutions?
Currently 55.049% of Vallon Pharmaceuticals shares are held by insiders and 21.454% by institutions. How many people work for Vallon Pharmaceuticals?
Latest data suggests 3 work at Vallon Pharmaceuticals. When does the fiscal year end for Vallon Pharmaceuticals?
Vallon Pharmaceuticals's fiscal year ends in December. Where is Vallon Pharmaceuticals based?
Vallon Pharmaceuticals's address is: Two Logan Square, Philadelphia, PA, United States, 19103 What is Vallon Pharmaceuticals's ISIN number?
Vallon Pharmaceuticals's international securities identification number is: US92023M1018
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert